Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
University of Louisville |
---|---|
Information provided by: | University of Louisville |
ClinicalTrials.gov Identifier: | NCT00116584 |
The purpose of this study is to assess whether children with moderate to severe bronchiolitis treated with standard racemic epinephrine therapy via 70:30 helium-oxygen (heliox) driven nebulization will have improvements in measurements of airway more rapidly than those treated with conventional air-oxygen driven nebulization.
Condition | Intervention | Phase |
---|---|---|
Bronchiolitis |
Drug: heliox |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind (Outcomes Assessor), Placebo Control, Single Group Assignment, Efficacy Study |
Official Title: | The Use of Heliox Driven Racemic Epinephrine Nebulization in the Treatment of Moderate to Severe Bronchiolitis in Pediatric Emergency Department Patients |
Estimated Enrollment: | 100 |
Study Start Date: | December 2004 |
Estimated Study Completion Date: | July 2009 |
Primary Completion Date: | March 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
heliox
heliox-driven nebulizations for children with moderate to severe bronchiolitis
|
Drug: heliox
continuous heliox therapy
|
Ages Eligible for Study: | 2 Months to 12 Months |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United States, Kentucky | |
Kosair Children's Hospital | |
Louisville, Kentucky, United States, 40202 |
Principal Investigator: | In K Kim, MD | University of Louisville, Dept. of Pediatrics, Div. of Pediatric Emergency Medicine |
Responsible Party: | University of Louisville ( In K. Kim, MD ) |
Study ID Numbers: | GRNT040954, GRNT040954 |
Study First Received: | June 29, 2005 |
Last Updated: | April 10, 2008 |
ClinicalTrials.gov Identifier: | NCT00116584 |
Health Authority: | United States: Food and Drug Administration |
heliox bronchiolitis racemic epinephrine |
Lung Diseases, Obstructive Respiratory Tract Infections Respiratory Tract Diseases Lung Diseases |
Bronchiolitis Emergencies Bronchitis Epinephrine |
Respiratory System Agents Neurotransmitter Agents Disease Attributes Adrenergic alpha-Agonists Adrenergic beta-Agonists Molecular Mechanisms of Pharmacological Action Adrenergic Agents Bronchial Diseases Sympathomimetics Physiological Effects of Drugs Anti-Asthmatic Agents |
Cardiovascular Agents Adrenergic Agonists Pharmacologic Actions Pathologic Processes Mydriatics Autonomic Agents Therapeutic Uses Vasoconstrictor Agents Peripheral Nervous System Agents Bronchodilator Agents |